Literature DB >> 10711458

Increased levels of circulating ICAM-1, E-selectin, and IL-2 receptors in celiac disease.

L Jelínková1, L Tucková, D Sánchez, S Krupicková, O Pozler, J Nevoral, R Kotalová, H Tlaskalová-Hogenová.   

Abstract

Adhesive interactions between endothelium and circulating cells are crucial for the development of inflammatory reactions. We found significantly higher serum levels of soluble intracellular adhesion molecule-1 (sICAM-1, 492.5 +/- 22.1 ng/ml) in patients with active celiac disease (including IgA-deficient patients) than in patients on a gluten-free diet (335.7 +/- 20.0 ng/ml) (P < 0.001) and healthy controls (207.4 +/- 11.2 ng/ml) (P < 0.001). The concentration of soluble E-selectin in sera from celiac patients (37.2 +/- 3.4 ng/ml) was also higher (P < 0.001) than in sera from healthy controls (15.5 +/- 0.7 ng/ml) but, in contrast to sICAM-1, it remained high in the patients after treatment (30.2 +/- 2.7 ng/ml). Interestingly, the concentration of circulating soluble interleukin-2 receptors, molecules indicating lymphocyte activation, was only increased in sera from patients with active celiac disease (2943.0 +/- 214.1 pg/ml), and the level in sera from treated patients and healthy controls was comparable (1936 +/- 349 and 1416 +/- 111.7 pg/ml). The elevated serum level of soluble cell adhesion molecules could be used as a supplementary, noninvasive procedure for monitoring intestinal immune reactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711458     DOI: 10.1023/a:1005489316037

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

Review 1.  Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance.

Authors:  A J Gearing; I Hemingway; R Pigott; J Hughes; A J Rees; S J Cashman
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

Review 2.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

3.  Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease.

Authors:  M Göke; J C Hoffmann; J Evers; H Krüger; M P Manns
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 4.  Endothelial-leukocyte adhesion molecules.

Authors:  M P Bevilacqua
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  Soluble interleukin 2 receptor levels in children with type I insulin-dependent diabetes mellitus.

Authors:  L A Gartner; M C Pfeifer; C Albini; G L Francis
Journal:  Ann Clin Lab Sci       Date:  1995 Jan-Feb       Impact factor: 1.256

6.  Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.

Authors:  M D Srivastava; T M Rossi; E Lebenthal
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1995-01

7.  Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis.

Authors:  O H Nielsen; J Brynskov; B Vainer
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

8.  Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.

Authors:  G Steiner; A Studnicka-Benke; G Witzmann; E Höfler; J Smolen
Journal:  J Rheumatol       Date:  1995-03       Impact factor: 4.666

9.  Expression of cell adhesion molecules in jejunum biopsies of children with coeliac disease.

Authors:  V Villanacci; F Facchetti; N Pillan; A Meini; C Donzelli; A G Ugazio
Journal:  Ital J Gastroenterol       Date:  1993-04

10.  Circulating soluble adhesion molecules in systemic vasculitis.

Authors:  A A Pall; D Adu; M Drayson; C M Taylor; N T Richards; J Michael
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

View more
  3 in total

1.  Gliadin peptides activate blood monocytes from patients with celiac disease.

Authors:  Jana Cinova; Lenka Palová-Jelínková; Lesley E Smythies; Marie Cerná; Barbara Pecharová; Milos Dvorák; Pavel Fruhauf; Helena Tlaskalová-Hogenová; Phillip D Smith; Ludmila Tucková
Journal:  J Clin Immunol       Date:  2007-01-27       Impact factor: 8.317

2.  Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity.

Authors:  Akshay Kapoor; A K Patwari; Praveen Kumar; Anju Jain; Shashi Narayan
Journal:  Indian J Pediatr       Date:  2012-07-06       Impact factor: 1.967

3.  Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.

Authors:  Essi Myrsky; Sergio Caja; Zsofi Simon-Vecsei; Ilma R Korponay-Szabo; Cristina Nadalutti; Russell Collighan; Alexandre Mongeot; Martin Griffin; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Life Sci       Date:  2009-08-13       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.